Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79163.991.4627%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Achieve Life Sciences Inc

ACHVNASDAQ
Trade with Public
Trade with Public
$8.49
0.182.17%
At close: Sep 4, 5:00 PM EST
$8.50
0.010.12%
After Hours: Sep 4, 6:49 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Achieve Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Achieve Life Sciences (ACHV).

Price Target Range — 10 Quarters

Analyst Consensus — 9 Analysts

2S.Buy
7Buy
Consensus RatingBuy# Analysts9Avg. Consensus PT$15Upside to Avg. PT+71.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 13, 2026Morgan StanleyMaxwell SkorInitiateOverweight$13
Jun 22, 2026HC Wainwright & Co.Brandon FolkesMaintainedBuy$12
More with Benzinga EdgeGet Access

Analyst Ratings News

This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

Wall Street analysts changed outlook on top names. Check analyst ratings page for all changes. See what analysts think of MTN stock.
Avi Kapoor

PRO
Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Overweight rating and announces Price Target of $13.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
Canaccord Genuity Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $13

Canaccord Genuity analyst Gary Nachman initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $13.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Buy and maintains $12 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Achieve Life Sciences, Maintains $12 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Achieve Life Sciences (NASDAQ:ACHV) with a Buy and maintains $12 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved